RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Versant Capital Management, Inc's Holding History (CIK: 0001735057)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 123 Value ($000) $1 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 54 Value ($000) $0 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 17 Value ($000) $0 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 1,235 Value ($000) $7 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 1,181 Value ($000) $8 Avg Close $6.72 Range $5.60 - $9.55

Q3 2024

Shares 147 Value ($000) $1 Avg Close $7.17 Range $5.88 - $8.73

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	123	$1	$4.95	$3.81 - $7.18
Q3 2025	54	$0	$5.25	$4.45 - $7.15
Q2 2025	17	$0	$4.91	$3.79 - $6.11
Q1 2025	1,235	$7	$7.29	$5.19 - $12.36
Q4 2024	1,181	$8	$6.72	$5.60 - $9.55
Q3 2024	147	$1	$7.17	$5.88 - $8.73